Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors
- 12 March 2001
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (5), 611-614
- https://doi.org/10.1016/s0960-894x(00)00681-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and SpecificityScience, 2000
- Phosphodiesterase 4 inhibitors as novel anti-inflammatory agentsCurrent Opinion in Chemical Biology, 1999
- 1,4-Cyclohexanecarboxylates: Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of AsthmaJournal of Medicinal Chemistry, 1998
- Synthesis of Pyrido[2,3-d]pyrimidines via Palladium-catalyzed Coupling Reaction Followed by Electrocyclic ReactionHETEROCYCLES, 1998
- SB-207499Drugs of the Future, 1998
- Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunctionBioorganic & Medicinal Chemistry Letters, 1996
- 1 Phosphodiesterase Type IV InhibitorsProgress in Medicinal Chemistry, 1996
- Chapter 8. Chronic Pulmonary Inflammation and Other Therapeutic Applications of PDE IV InhibitorsAnnual Reports in Medicinal Chemistry, 1996
- Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesteraseJournal of Medicinal Chemistry, 1991
- Stereospecific binding of the antidepressant rolipram to brain protein structuresEuropean Journal of Pharmacology, 1986